NATERA INC (NTRA) Stock News

NASDAQ:NTRA - Nasdaq - US6323071042 - Common Stock - Currency: USD

163.02 +4.58 (+2.89%)

After market: 162.75 -0.27 (-0.17%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

NTRA Latest News, Press Relases and Analysis

All

Press Releases

3 days ago - By: Benzinga

$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today

4 days ago - By: Benzinga

5 Analysts Have This To Say About Natera

8 days ago - By: The Motley Fool

Natera (NTRA) Q2 Revenue Jumps 32%

8 days ago - By: Zacks Investment Research

Compared to Estimates, Natera (NTRA) Q2 Earnings: A Look at Key Metrics

8 days ago - By: Zacks Investment Research - Mentions: AUNA

Natera (NTRA) Reports Q2 Loss, Tops Revenue Estimates

8 days ago - By: The Motley Fool

Natera NTRA Q2 2025 Earnings Call Transcript

8 days ago - By: Natera, Inc.

Natera Reports Second Quarter 2025 Financial Results

9 days ago - By: Natera, Inc.

Natera Launches Fetal Focus™: A Noninvasive Prenatal Test for Inherited Conditions

11 days ago - By: Zacks Investment Research - Mentions: MD

Pediatrix Medical Group (MD) Q2 Earnings and Revenues Top Estimates

15 days ago - By: Natera, Inc.

Natera Highlights Latest Prospera™ Data at WTC 2025; 16 Abstracts Including Five Oral Presentations

16 days ago - By: Natera, Inc.

Natera to Report Its Second Quarter Results on August 7, 2025

18 days ago - By: Natera, Inc.

Natera Announces Launch of ABCSG 61 (“TEODOR”), a Randomized Controlled Trial of Signatera™ in Early-Stage Breast Cancer

23 days ago - By: Natera, Inc.

PEDAL Study Successful, Shows Monitoring with Prospera™ Kidney Provides Accurate Prognosis of Long-Term Clinical Outcomes Following Rejection; Now Published in AJT

a month ago - By: Yahoo Finance - Mentions: VZ

Natera, Inc. (NTRA): A Bull Case Theory

a month ago - By: Natera, Inc.

Natera Presents Data at ESMO GI on its Tissue-Free Latitude™ MRD* Assay, Demonstrating Excellent Overall Performance in Colorectal Cancer

a month ago - By: Yahoo Finance

Should You Invest in Natera (NTRA)?

2 months ago - By: Natera, Inc.

Natera to Present Clinical and Economic Utility of Signatera at ESMO GI, Highlights Innovations in MRD